Author:
Tice Raymond R.,Bassan Arianna,Amberg Alexander,Anger Lennart T.,Beal Marc A.,Bellion Phillip,Benigni Romualdo,Birmingham Jeffrey,Brigo Alessandro,Bringezu Frank,Ceriani Lidia,Crooks Ian,Cross Kevin,Elespuru Rosalie,Faulkner David M.,Fortin Marie C.,Fowler Paul,Frericks Markus,Gerets Helga H.J.,Jahnke Gloria D.,Jones David R.,Kruhlak Naomi L.,Piparo Elena Lo,Lopez-Belmonte Juan,Luniwal Amarjit,Luu Alice,Madia Federica,Manganelli Serena,Manickam Balasubramanian,Mestres Jordi,Mihalchik-Burhans Amy L.,Neilson Louise,Pandiri Arun,Pavan Manuela,Rider Cynthia V.,Rooney John P.,Trejo-Martin Alejandra,Watanabe-Sailor Karen H.,White Angela T.,Woolley David,Myatt Glenn J.
Funder
NIEHS
National Institutes of Health
Subject
Health, Toxicology and Mutagenesis,Computer Science Applications,Toxicology
Reference279 articles.
1. WHO, World Health Organization Cancer Fact Sheet, (2020). https://www.who.int/news-room/fact-sheets/detail/cancer (accessed October 20, 2020).
2. Facts and theories concerning the mechanisms of carcinogenesis;Pitot;FASEB J.,1991
3. Predicting the carcinogenic potential of pharmaceuticals in rodents using molecular structural similarity and E-state indices;Contrera;Regul. Toxicol. Pharmacol.,2003
4. D. Guo, N.L. Kruhlak, L. Stavitskaya, K.P. Cross, D.A. Bower, Characterizing compound classes by rodent carcinogenicity tumor severity and type, in: Baltimore, MD, 2016. https://doi.org/10.1177/1091581816686042.
5. An analysis of genetic toxicity, reproductive and developmental toxicity, and carcinogenicity data: I. Identification of carcinogens using surrogate endpoints;Matthews;Regul. Toxicol. Pharmacol.,2006